HomeNews Federal News

Federal News

Displaying results 1-10 (of 85)
 |<  < 1 2 3 4 5 6 7 8 9  >  >| 

HHS Issues Slew of Clarifications for Provider Relief Fund Recipients

posted: June 26, 2020 to Federal

After announcing plans to distribute an addition $15 billion to participants in state Medicaid and CHIP programs, the Department of Health and Human Services issued a number of clarifications for providers who received funds from the general distribution fund.

READ MORE

CSRO Comments on CMS Telehealth and Home Administration

posted: April 30, 2020 to Federal

In response to rapidly evolving circumstances surrounding the COVID-19 pandemic, CMS has made numerous interim revisions to its policies. These changes are designed to streamline patient access to care during the pandemic and large scale social distancing.

READ MORE

Add to the COVID-19 Global Rheumatology Alliance Registry

posted: April 8, 2020 to CSRO News, Federal

CSRO is imploring its membership to utilize the COVID-19 Global Rheumatology Alliance Healthcare Provider Entered Registry during the unprecedented era of global pandemic.

READ MORE

CSRO Opposes New Policy by BCBS Tennessee

posted: January 29, 2020 to CSRO News, Federal

CSRO physicians are voicing concern for patients who will fall victim of a dangerous new prescription policy. New requirements from BlueCross BlueShield (BCBS) of Tennessee, which may be a bellwether for other insurers, are reversing the trend providers have achieved in keeping prices down for physician administered medications.

READ MORE

Federal Rebate Rule Withdrawn by White House

posted: July 12, 2019 to Federal

On July 11th, the White House announced that it was withdrawing its proposal to reformulate the way drug rebates work in federal programs.

READ MORE

CMS Issues Final Rule Affecting Patient Access and Prescription Drug Affordability

posted: June 14, 2019 to Federal

The Centers for Medicare and Medicaid (CMS) published its “Medicare Advantage and Part D Drug Pricing Final Rule” in May which seeks to increase drug pricing transparency, lower prescription drug costs, and improve patient medication adherence.

READ MORE

CSRO President Testifies Before Congress

posted: May 30, 2019 to CSRO News, Federal

Last week, the House Energy and Commerce Subcommittee on Health held a hearing entitled: “Improving Drug Pricing Transparency and Lowering Prices for American Consumers.” CSRO President, Dr. Madelaine Feldman, was invited to represent the Alliance for Specialty Medicine and deliver testimony at the hearing.

READ MORE

FDA Releases Final Guidance on Interchangeable Biosimilars

posted: May 24, 2019 to Federal

Last week, the FDA released its long anticipated final guidance for industry on “Considerations in Demonstrating Interchangeability with a Reference Product.”

READ MORE

CSRO offers Federal Policy Virtual “Town Hall” to Rheumatology Community

posted: April 9, 2019 to CSRO News, Federal

The gridlock immobilizing Congress has slowed the progress of health care legislation significantly, but it has not stopped key Federal agencies from proposing and implementing policies that have a far reaching impact on the practice of rheumatology.

READ MORE

CSRO Comments on Proposed Rule to Eliminate Safe Harbor Protections for Prescription Drug Rebates

posted: April 8, 2019 to CSRO News, Federal

The Coalition of State Rheumatology Organizations (CSRO) recently submitted comments on the Department of Health and Human Services (HHS) proposed rule amending the Federal anti-kickback statute.

READ MORE

Displaying results 1-10 (of 85)
 |<  < 1 2 3 4 5 6 7 8 9  >  >|